The Patent Finder

Marval Pharma, Inc.

Also on record
Records under this name other than patents Marval Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Marval Pharma, Inc.

PatentTitleStatus Expires Confidence
US 8,911,708Nano-scale contrast agents and methods of use
Lapsed on the fee record
Ended Dec 16, 2022 · From the USPTO record
Lapsed on the fee recordEnded Dec 16, 2022From the USPTO record
US 7,785,568Compositions and Methods for Enhancing Contrast in Imaging
Lapsed on the fee record
Ended Aug 31, 2022 · High confidence
Lapsed on the fee recordEnded Aug 31, 2022High confidence
US 8,357,351Nano-Scale Contrast Agents and Methods of Use
Lapsed on the fee record
Ended Jan 22, 2021 · High confidence
Lapsed on the fee recordEnded Jan 22, 2021High confidence
US RE45,195Compositions and Methods for Enhancing Contrast in Imaging
Lapsed on the fee record
Ended May 11, 2018 · Low confidence
Lapsed on the fee recordEnded May 11, 2018Low confidence
US 7,713,517Compositions and Methods for Enhancing Contrast in Imaging
Surrendered on reissue
Surrendered on reissue Oct 14, 2014 · Low confidence
Surrendered on reissueSurrendered on reissue Oct 14, 2014Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited